Metabolism-Clinical and Experimental

Papers
(The H4-Index of Metabolism-Clinical and Experimental is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Adipose ZFP36 protects against diet-induced obesity and insulin resistance570
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and MultipleAscending Dose Study of AMG 133 in Subjects with Obesity464
Carbohydrate restriction-induced elevations in LDL-cholesterol and atherosclerosis: The KETO Trial335
Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma252
PCSK9 in metabolism and diseases177
Telomere length of the gums of patients with diabetes mellitus in non-alcoholic fatty liver disease173
Editorial Board167
miRNAs and Endothelin: A potential nexus in the roadmap for diabetes linked cardiac complications therapeutic strategy160
Features of myocardial damage indexes in patients with metabolic syndrome and nonalcoholic fatty liver disease158
The impact of chronic kidney disease in diabetic COVID-19 patients151
The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland144
Features of Ultrastructural Changes in Type II Alveolocytes in Young Rats On the Background of Chronic Hyperglycemia126
Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters117
Vitamin D status and its Association with Atherogenic Index of Plasma in Young Subjects with PCOS108
Patient perspectives and experiences of basal insulin (BI) titration in type 2 diabetes (T2D): A US cross-sectional survey107
Gestational Diabetes Mellitus: increased incidence during the COVID-19 pandemic103
Diabetes mellitus: 100 years since the discovery of insulin90
Single Nucleotide Variants of the PNPLA3 Gene are Important Genetic Modifiers for the Progression of Metabolically Unhealthy Obesity in Children89
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications87
Efficacy and Safety of Tirzepatide in Type 2 Diabetes: The SURPASS Clinical Trial Program87
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults86
AAV-Mediated Pancreatic Gene Therapy for Type-2 Diabetes84
Thymoquinone: A Promising Anti-diabetic Molecule!82
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History79
Editorial Board76
Hearing loss in inherited metabolic disorders: A systematic review75
One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs72
COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?69
Editorial Board68
Editorial Board64
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery63
Effectiveness and Safety of the Combination of Gliclazide with Metformin in Patients with Diabetes Type 263
The Role of Next Generation Sequencing for the Pr ediction of Clinical Outcome in Nonischemic Dilated Cardiomyopathy62
BODY WEIGHT CHANGE IN HYPERCOLESTROLEMIC RATS MODEL AFTER INTERVENTION WITH AVOCADO (Persea americana Mill) JUICE61
Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter60
Diabetes knowledge and associated factors in rural Eastern Cape, South Africa: A cross sectional study59
Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages57
Disruptive factors of treatment adherence of diabetic patients in downtown Sfax from Tunisia – a community pharmacy-based survey56
Comparative efficacy of Gan & Lee insulin aspart (GL-ASP) and EU-marketed insulin aspart (NN-ASP), when combined with metformin, in patients with diabetes mellitus: Post-hoc analyses from a multic55
Exploring interactions among clustered components of Metabolic Syndrome with diabetes and prediabetes in The Study of Cardiovascular Risk Factors in Adolescents – ERICA Study55
Autoimmune pancreatitis and its relevance55
Editorial Board53
Scientific evaluation of a folk herbal compound for antihyperglycemic and associated bio health markers in chemically induced diabetic rat model52
Insulin resistance and miR-143/miR-145 relative expression profile is associated with dysregulation in the pathological adiposity setting in aging51
HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation50
MiR-21 and MiR-133b are Functionally Associated with Atherosclerotic Coronary Artery Disease by Modulating the Expression of their Novel Targets ATG5, LRP6 and SGPP147
Editorial Board47
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset47
0.099343061447144